BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260414
DTEND;VALUE=DATE:20260417
DTSTAMP:20260514T232942
CREATED:20251125T111346Z
LAST-MODIFIED:20251125T111346Z
UID:42493-1776124800-1776383999@www.pharmajournalist.com
SUMMARY:3rd Annual GLP-1 Based Therapeutics Summit
DESCRIPTION:Welcome to the 3rd GLP-1 Based Therapeutics Summit – the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations\, mastering tolerability\, drug delivery\, and seizing the multi-billion dollar opportunity in non-obesity indications. \nDriven by unprecedented clinical success\, this revolutionary drug class has created multi-billion dollar franchises\, but the market is now reaching a critical juncture where differentiation is everything. The pressure is on to move beyond monotherapy and unlock new levels of efficacy in areas like neuroscience and cardiorenal protection\, promising unparalleled potential to conquer widespread chronic diseases. \nThe 3rd GLP-1 Based Therapeutics Summit stands as the global forum for experts dedicated to accelerating this vital progress. This year\, we’re diving deep into the game-changing potential of multi-agonist combinations\, next-generation tolerability\, and strategic commercial planning. \nHear from the titans of the pharmaceutical industry\, including Eli Lilly\, AstraZeneca\, Merck\, and Takeda\, as well as innovative biotechs and financial institutions who will share their groundbreaking research and strategies for developing best-in-class treatments that transform patient lives. \nView the full event guide: https://ter.li/p453jn
URL:http://www.pharmajournalist.com/event/3rd-annual-glp-1-based-therapeutics-summit/
LOCATION:Hotel Commonwealth\, 500 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR